Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the International Letrozole Breast Cancer Group (vol 19, pg 2596, 2001)

被引：0

|

作者：

Mouridsen

机构：

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2001年 / 19卷 / 13期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：3302 / 3302

页数：1

相关论文

共 50 条

[1] Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: Results of a phase III study of the International Letrozole Breast Cancer Group
Illiger, HJ
[J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (02) : 111 - 113
[2] Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer:: Results of a phase III study of the international letrozole breast cancer group
Mouridsen, H
Gershanovich, M
Sun, Y
Pérez-Carrión, R
Boni, C
Monnier, A
Apffelstaedt, J
Smith, R
Sleeboom, HP
Jänicke, F
Pluzanska, A
Dank, M
Becquart, D
Bapsy, PP
Salminen, E
Snyder, R
Lassus, M
Verbeek, JA
Staffler, B
Chaudri-Ross, HA
Dugan, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (10) : 2596 - 2606
[3] Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women:: Analysis of survival and update of efficacy from the international letrozole breast cancer group
Mouridsen, H
Gershanovick, M
Sun, Y
Pérez-Carrión, R
Boni, C
Monnier, A
Apffelstaedt, J
Smith, R
Sleeboom, HP
Jaenicke, F
Pluzanska, A
Dank, M
Becquart, D
Bapsy, PP
Salminen, E
Snyder, R
Chaudri-Ross, H
Lang, R
Wyld, P
Bhatnagar, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) : 2101 - 2109
[4] Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: Analysis of survival and update of efficacy from the international letrozole breast cancer group
Buzdar, AU
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3199 - 3200
[5] Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: Analysis of survival and update of efficacy from the international letrozole breast cancer group - Reply
Mouridsen, H
Chaudri-Ross, HA
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (15) : 3200 - 3201
[6] Efficacy of first-line letrozole versus tamoxifen as a function of age in postmenopausal women with advanced breast cancer
Mouridsen, H
Chaudri-Ross, HA
[J]. ONCOLOGIST, 2004, 9 (05): : 497 - 506
[7] A Stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy - For advanced breast cancer in postmenopausal patients
Karnon, J
Jones, T
[J]. PHARMACOECONOMICS, 2003, 21 (07) : 513 - 525
[8] A stochastic economic evaluation of letrozole versus tamoxifen as a first-line hormonal therapy for advanced breast cancer in postmenopausal patients in Germany
Fricke, FU
Quednau, K
Pirk, O
[J]. VALUE IN HEALTH, 2002, 5 (06) : 443 - 443
[9] Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women:: Results of the tamoxifen or arimidex randomized group efficacy and tolerability study
Bonneterre, J
Thürlimann, B
Robertson, JFR
Krzakowski, M
Mauriac, L
Koralewski, P
Vergote, I
Webster, A
Steinberg, M
von Euler, M
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (22) : 3748 - 3757
[10] A Stochastic Economic Evaluation of Letrozole versus Tamoxifen as a First-Line Hormonal TherapyFor Advanced Breast Cancer in Postmenopausal Patients
Jon Karnon
Trefor Jones
[J]. PharmacoEconomics, 2003, 21 : 513 - 525

← 1 2 3 4 5 →